- Home
- / Rich Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Rich Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2021-11-01
Market Capitalization
$941.9 K
2021-11-01
Revenue
$115 K
FY, 2018
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 115.0K | ||||||
| Cost of goods sold | 335.0K | 200.9K | 16.0K | 45.6K | |||
| Gross profit | (335.0K) | (200.9K) | |||||
| Operating expense total | 2.7M | 3.4M | 16.8K | 71.9K | 332.6K | ||
| Depreciation and amortization | 158.0 | 473.0 | 799.0 | 1.6K | 1.2K | ||
| EBIT | (31.9K) | (31.3K) | (3.0M) | (3.6M) | (1.1M) | (951.8K) | (1.3M) |
| EBIT margin, % | -1162.1% | ||||||
| Interest expense | 56.5K | 185.1K | 224.8K | 663.6K | |||
| Pre tax profit | (3.0M) | (4.1M) | (1.8M) | (3.2M) | (1.7M) | ||
| Net Income | (31.9K) | (31.3K) | (3.0M) | (4.1M) | (1.8M) | (3.2M) | (1.7M) |